Barbara Erber
Berlin, BE 10117, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
High level expression of glucocorticoid receptor (GR) is linked to aggressive tumor features, early biochemical recurrence, and genetic instability in prostate cancer.
Journal: Prostate cancer and prostatic diseases
Published: November 29, 2024
Reduced monocytic IL10 expression in PD1 inhibitor-treated patients is a harbinger of severe immune-related adverse events.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 29, 2024
Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomy.
Journal: The oncologist
Published: February 06, 2024
Explorative analysis of a score predicting the therapy response of patients with metastatic, castration resistant prostate cancer undergoing radioligand therapy with 177Lu-labeled prostate-specific membrane antigen.
Journal: Annals of nuclear medicine
Published: June 02, 2020
Oncological outcomes, quality of life outcomes and complications of partial cystectomy for selected cases of muscle-invasive bladder cancer.
Journal: Scientific reports
Published: November 22, 2017
Urolithiasis in Renal Allografts: Complications and Outcomes.
Journal: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
Published: November 19, 2016
Prevalence of Late-Onset Hypogonadism in Men with Localized and Metastatic Renal Cell Carcinoma.
Journal: Urologia internationalis
Published: January 25, 2016
Retrospective Analysis of Fifth-Line Targeted Therapy Efficacy in Patients with Metastatic Renal Cell Carcinoma.
Journal: Urologia internationalis
Published: January 12, 2016
Efficacy of fourth-line targeted therapy in patients with metastatic renal cell carcinoma: a retrospective analysis.
Journal: World journal of urology
Published: September 18, 2015
Last Updated: 09/26/2026